Comparison of 18Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma

Leukemia and Lymphoma

Volumn 48, Issue 4, 2007, Pages 699-707

  Mody, Rajen J ^a   Bui, Chuong ^a   Hutchinson, Raymond J ^a   Frey, Kirk A ^a   Shulkin, Barry L ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

FDG; Fluorodeoxyglucose; Gallium; Hodgkin; Lymphoma; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; ANTINEOPLASTIC AGENT; GALLIUM;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPHOMA; MALE; MEDICAL INFORMATION; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRICS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCAR; SCHOOL CHILD; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; TOTAL QUALITY MANAGEMENT; CHILD; COMPARATIVE STUDY; HODGKIN DISEASE; METHODOLOGY; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; SCINTISCANNING;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; HODGKIN DISEASE; HUMANS; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34247266647     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601179783     Document Type: Article

References (32)

1. Gurney, J. G., Severson, R. K., Davis, S. and Robinson, L. L. (1995) Incidence of cancer in children in the United States. Sex-, race- and 1-year age-specific rates by histologic type. Cancer, 75, pp. 2186-2195.
2. Philip, T., Bergeron, C. and Frappaz, D. (1996) Management of paediatric lymphoma. Baillieres Clin Haematol, 9, pp. 769-797.
3. DeVita Jr, V. T. and Canellos, G. P. (1999) The lymphomas. Semin Hematol, 36, pp. 84-94.
4. Jochelson, M., Mauch, P., Balikian, J., Rosenthal, D. and Canellos, G. (1985) The significance of the residual mediastinal mass in treated Hodgkin's disease. J Clin Oncol, 3, pp. 637-640.
5. Bar-Shalom, R., Mor, M. and Yefremov, N. (2001) The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment. Sem Nucl Med, 31, pp. 177-190.
6. Bekerman, C., Hoffer, P. B. and Bitran, J. D. (1984) The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med, 14, pp. 296-323.
7. Kostakoglu, L., Leonard, J. P., Kuji, I., Coleman, M., Vallabhajosula, S. and Goldsmith, S. J. (2002) Comparison of fluorine-18 fluorodeoxyglucose positron emission tomorgraphy and Ga-67 scintigraphy in evaluation of lymphoma. Cancer, 94, pp. 879-888.
8. Tan, T. X. and Gelfand, M. J. (1996) Ga-67 scintigraphy in pediatric patients. Comparison of extended SPECT of the chest and abdomen with planar imaging. Clin Nucl Med, 21, pp. 717-719.
9. Montravers, F., McNamara, D., Landman-Parker, J., Grahek, D., Kerrou, K. and Younsi, N. (2002) 18F-FDG in childhood lymphoma: Clinical utility and impact on management. Eur J Nucl Med, 29, pp. 1155-1165.
10. Schoder, H., Meta, J., Yap, C., Ariannejad, M., Rao, J. and Phelps, M. E. (2001) Effect of whole-body 18F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med, 42, pp. 1139-1143.
11. Hoh, C. K., Glaspy, J., Rosen, P., Dahlbom, M., Lee, S. J. and Kunkel, L. (1997) Whole-body PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med, 38, pp. 343-348.
12. Buchmann, I., Reinhardt, M., Elsner, K., Bunjes, D., Altehoefer, C. and Finke, J. (2001) 2(Fluorine-18) fluoro-2-deoxy--glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer, 91, pp. 889-899.
13. Spaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J. and Vandenberghe, P. (2001) Prognostic value of positron emission topmography (PET) with fluorine-18 fluoro-deoxyglucose (18F-FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: Is 18F-FDG-PET a valid alternative to conventional diagnostic methods?. J Clin Oncol, 19, pp. 414-419.
14. Tatsumi, M., Kitayama, H., Sugahara, H., Tokita, N., Nakamura, H. and Kanakura, Y. (2001) Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma. J Nucl Med, 42, pp. 601-608.
15. Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I. and Connors, J. M. (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored Working Group. J Clin Oncol, 17, pp. 1244-1253.
16. Israel, O., Keidar, Z. and Bar-Shalom, R. (2004) Positron emission tomography in the evaluation of lymphoma. Semin Nucl Med, 34, pp. 166-179.
17. Friedberg, J. W., Fischman, A., Neuberg, D., Kim, H., Takvorian, T. and Ng, A. K. (2004) FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma. Leuk Lymphoma, 45, pp. 85-92.
18. Mody, R., Shulkin, B., Yanik, G., Hutchinson, R. and Castle, V. (2001) PET FDG imaging in pediatric lymphomas. J Nucl Med, 42, p. 39.
19. Bui, C., Shulkin, B., Mody, R., Shreve, P. D., Strouse, P. J. and Lahti, L. D. (2002) FDG-PET imaging of lymphomas in pediatric patients. Radiology, 225, p. 285.
20. Rini, J. N., Nunex, R., Nichols, K., Tonco, G. G., Tomas, M. and Hart, D. (2005) Coincidence-detection FDG-PET versus gallium in children and young adults with newly diagnosed Hodgkin's disease. Pediatr Radiol, 35, pp. 169-178.
21. Depas, G., DeBarsy, C., Jerusalem, G., Hoyoux, C., Dresse, M. and Fassotte, M. (2005) 18F-FDG PET in children with lymphomas. Eur J Nucl Med, 32, pp. 31-38.
22. Kabickova, E., Sumerauer, D., Cumlivska, E., Drahokoupilova, E., Nekolna, M. and Chanova, M. (2006) Comparison of (18)F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. Eur J Nucl Med Mol Imaging, 33, pp. 1025-1031.
23. Hernandez-Pampaloni, M., Takalkar, A., Yu, J. Q., Zhuang, H. and Alavi, A. (2006) F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatr Rad, 36, pp. 524-531.
24. Westerterp, M., Pruim, J., Oyen, W., Hoekstra, O., Paans, A. and Visser, E. (2006) Quantification of FDG PET studies using standardised uptake values in multi-centre trials: Effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging
25. Keyes Jr, J. W. (1995) SUV: Standard uptake or silly useless value?. J Nucl Med, 36, pp. 1836-1839.
26. Wirth, A., Seymour, J. F. and Hicks, R. J. (2002) Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. Am J Med, 112, pp. 262-268.
27. Bossche, B Van den, Lambert, B. and De Winter, F. (2002) 18-FDG PET versus high-dose Ga-67 scintigraphy for restaging and treatment follow up of lymphoma patients. Nucl Med Commun, 23, pp. 1079-1083.
28. Valentin, D. J. (1998) Recalculated dose data for 19 frequently used radiopharmaceuticals from ICRP Publication 53. Ann ICRP, 28, pp. 47-83.
29. Korholz, D., Claviez, A., Hasenclever, D., Kluge, R., Hirsch, W. and Kamprad, F. (2004) The concept of the GOPH-HD 2003 therapy study for pediatric Hodgkin's disease: Evolution in the tradition of the DAL/GPOH studies. Kiln Padiatr, 216, pp. 150-155.
30. Korholz, D., Kluge, R., Wickmann, L., Hirsch, W., Luders, H. and Lotz, I. (2003) Importance of F18-fluorodexoy--2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence-consequences for the GPOH-HD 2003 protocol. Onkologie, 26, pp. 489-493.
31. Hudson, M. M., Krasin, M. J. and Kaste, S. C. (2004) PET imaging in pediatric Hodgkin's lymphoma. Pediatr Radiol, 34, pp. 190-198.
32. Kaste, S. C., Howard, S. C., McCarville, E. B., Krasin, M. J., Kogos, P. G. and Hudson, M. M. (2005) 18F-FDG avid sites mimicking active disease in pediatric Hodgkin's. Pediatr Radiol, 35, pp. 141-154.